Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage ...
In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...
PLEASANT GROVE, Utah, Jan. 29, 2026 /PRNewswire/ -- Renew Biotechnologies (Renew) today announced its role as the clinical testing provider for Path Fertility's NOA Guide, a newly launched epigenetic ...
Prediabetes is an extremely heterogeneous metabolic disorder. Scientists from several partner institutes of the German Center ...
Germany: Researchers have identified 1,557 blood-based epigenetic markers that can assess the risk of developing type 2 ...